Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease

Thrombosis Research

Volumn 113, Issue 1, 2004, Pages 57-65

  Lindman, Anja S ^a,b   Pedersen, Jan I ^a,b   Arnesen, Harald ^c   Hjerkinn, Elsa M ^c   Veierød, Marit B ^b   Prydz, Hans ^b   Seljeflot, Ingebjørg ^c  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Activated FVII; Choline containing phospholipids; Coagulation factor FVII; Coagulation factor VII; FVII; FVII antigen; FVII coagulant activity; FVIIa; FVIIag; FVIIc; MI; Myocardial infarction; PC; Phospholipids; Polymorphisms; TC; TG; Total cholesterol; Triglycerides

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7C; CHOLINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE; GENOTYPE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION;

EID: 1842737703     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.02.001     Document Type: Article

References (33)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. Mechanisms of disease - the pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 326:1992;242-250.
2. Rao L.V.M., Rapaport S.I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6687-6691.
3. Meade T.W., Mellows S., Brozovic M., Miller G.J., Chakrabarti R.R., North W.R.et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet. 2:1986;533-537.
4. Heinrich J., Balleisen L., Schulte H., Assmann G., van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler. Thromb. 14:1994;54-59.
5. Folsom A.R., Wu K.K., Shahar E., Davis C.E. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study investigators. Arterioscler. Thromb. 13:1993;1829-1836.
6. Cooper J.A., Miller G.J., Bauer K.A., Morrissey J.H., Meade T.W., Howarth D.J.et al. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation. 102:2000;2816-2822.
7. Eriksson-Berg M., Silveira A., Orth-Gomer K., Hamsten A., Schenck-Gustafsson K. Coagulation factor VII in middle-aged women with and without coronary heart disease. Thromb. Haemost. 85:2001;787-792.
8. Green F., Kelleher C., Wilkes H., Temple A., Meade T., Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler. Thromb. 11:1991;540-546.
9. Bernardi F., Arcieri P., Bertina R.M., Chiarotti F., Corral J., Pinotti M.et al. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler. Thromb. Vasc. Biol. 17:1997;2548-2553.
10. Bernardi F., Marchetti G., Pinotti M., Arcieri P., Baroncini C., Papacchini M.et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler. Thromb. Vasc. Biol. 16:1996;72-76.
11. Girelli D., Russo C., Ferraresi P., Olivieri O., Pinotti M., Friso S.et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N. Engl. J. Med. 343:2000;774-780.
12. Iacoviello L., DiCastelnuovo A., de Knijff P., D'Orazio A., Amore C., Arboretti R.et al. Polymorphism in the coagulation factor VII gene and the risk of myocardial infarction. N. Engl. J. Med. 338:1998;79-85.
13. Lane A., Green F., Scarabin P.Y., Nicaud V., Bara L., Humphries S.et al. Factor VII Arg/Gln (353) polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 119:1996;119-127.
14. Batalla A., Alvarez R., Reguero J.R., Gonzalez P., Alvarez V., Cubero G.I.et al. Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men. Int. J. Cardiol. 80:2001;209-212.
15. Humphries S.E., Lane A., Green F.R., Cooper J., Miller G.J. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor-VII genotype and plasma triglyceride concentration. Arterioscler. Thromb. 14:1994;193-198.
16. Feng D.L., Tofler G.H., Larson M.G., O'Donnell C.J., Lipinska I., Schmitz C.et al. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease - the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 20:2000;593-600.
17. Mariani G., Bernardi F., Bertina R., Vicente V.V., Prydz H., Samama M.et al. Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart" Haematologica. 84:1999;620-626.
18. Dalaker K., Hjermann I., Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br. J. Haematol. 61:1985;315-322.
19. Hjermann I., Holme I., Byre K.V., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease - report from the Oslo Study Group of a randomized trial in healthy men. Lancet. 2:1981;1303-1310.
20. Hjerkinn EM, Arnesen H, Hjermann I. Diet and omega-3 fatty acid intervention trial on atherosclerosis (DOIT-study). Atherosclerosis 2000;151:147. Abstract.
21. O'Hara P.J., Grant F.J., Haldeman B.A., Gray C.L., Insley M.Y., Hagen F.S.et al. Nucleotide-sequence of the gene coding for human factor-VII, a vitamin-K-dependent protein participating in blood-coagulation. Proc. Natl. Acad. Sci. U. S. A. 84:1987;5158-5162.
22. Takayama M., Itoh S., Nagasaki T., Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin. Chim. Acta. 79:1977;93-98.
23. Sham P. Statistics in human genetics. Arnold applications of statistics. 1998.
24. Moor E., Silveira A., van'tHooft F., Suontaka A.M., Eriksson P., Blomback M.et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler. Thromb. Vasc. Biol. 15:1995;655-664.
25. Lee A.J., Fowkes F.G.R., Lowe G.D.O., Connor J.M., Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk at coronary and peripheral atherosclerosis: Edinburgh artery study. Thromb. Haemost. 81:1999;553-560.
26. Nishiuma S., Kario K., Nakanishi K., Yakushijin K., Kageyama G., Matsunaka T.et al. Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls. Blood Coagul. Fibrinolysis. 8:1997;525-530.
27. Song J., Yoon Y.M., Jung H.J., Hong S.H., Park H., Kim J.Q. Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353->Gln polymorphism in Korean patients with coronary artery disease. J. Korean Med. Sci. 15:2000;146-152.
28. Wang X.L., Wang J., McCredie R.M., Wilcken D.E.L. Polymorphisms of factor V, factor VII, and fibrinogen genes - relevance to severity of coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;246-251.
29. Wu A.H.B., Tsongalis G.J. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am. J. Cardiol. 87:2001;1361-1366.
30. Liu Y., Heng C.K., Saha N., Hong S., Low P.S. Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese. Blood Coagul. Fibrinolysis. 13:2002;217-224.
31. Stengard J.H., Salomaa V., Rasi V., Vahtera E., Ehnholm C., Krusius T.et al. Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study. Blood Coagul. Fibrinolysis. 12:2001;445-452.
32. Hunault M., Arbini A.A., Lopaciuk S., Carew J.A., Bauer K.A. The Arg(353)Gln polymorphism reduces the level of coagulation factor VII - in vivo and in vitro studies. Arterioscler. Thromb. Vasc. Biol. 17:1997;2825-2829.
33. Miller G.J., Bauer K.A., Barzegar S., Cooper J.A., Rosenberg R.D. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb. Haemost. 75:1996;767-771.